Explore Protein-Protein Interactions for Cancer Target Discovery Using the OncoPPi Portal.
Methods Mol Biol. 2020, 2074, 145-164.The OncoPPi Portal: an integrative resource to explore and prioritize protein-protein interactions for cancer target discovery.
Bioinformatics, 2018, 34, 1183-1191.The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.
Nat. Commun. 2017, 8, 14356 doi: 10.1038/ncomms14356.OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.
Oncogene. 2017, 36, 5852-5860.AKT1, LKB1, and YAP1 revealed as MYC interactors with NanoLuc-based protein-fragment complementation assay.
Mol Pharmacol. 2017, 4, 339-347. doi: 10.1124/mol.116.107623.BRET: NanoLuc-Based Bioluminescence Resonance Energy Transfer Platform to Monitor Protein-Protein Interactions in Live Cells.
Methods Mol Biol. 2016, 1439, 263-71.The Emory Chemical Biology Discovery Center: leveraging academic innovation to advance novel targets through HTS and beyond. Comb. Chem.
High Throughput Screen., 2014, 17, 290-6.Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform. J. Mol. Cell Biol., 2015.
Targeting protein-protein interactions as an anticancer strategy.
Thrends Pharmacol. Sci., 2013, 34, 393-400.